Keros Therapeutics - 53 Year Dividend History | KROS
Historical dividend payout and yield for Keros Therapeutics (KROS) since 1971. The current TTM dividend payout for Keros Therapeutics (KROS) as of November 01, 2024 is $0.00. The current dividend yield for Keros Therapeutics as of November 01, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$2.249B |
$0.000B |
|
Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of novel treatments for hematological and musculoskeletal disorders. The company's product pipeline consists of KER-050, KER-047and KER-012 which are in clinical stage. Keros Therapeutics, Inc. is based in LEXINGTON, MA.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
